Ophthalmology · Worcester, MA
NPI
1679555825
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
33 Lincoln St
Worcester, MA, 01605
Phone (508) 757-4160
Groups this clinician bills Medicare through
Medicare paid, 2024
$175K
2,032 services
Medicare patients, 2024
917
Average age 71
Drug cost, 2024
$1.8M
5,678 prescriptions
Company payments, 2025
$446
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy B Meltzer was code 92014 (ophthalmological e&m), 884 times for 723 patients. In total Jeremy B Meltzer billed 2,032 services in 30 codes, and Medicare paid $175K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 884 | 723 | $81.07 | $72K |
| 99214 Office E&M - Established | Office | 222 | 180 | $94.67 | $21K |
| 92136 Ultrasound - Nonspecific | Office | 145 | 74 | $18.92 | $2,743 |
| 92134 Computerized Ophthalmic Imaging | Office | 115 | 93 | $29.34 | $3,374 |
| 92133 Computerized Ophthalmic Imaging | Office | 102 | 96 | $23.43 | $2,390 |
| 92083 Vision, Hearing, and Speech Services | Office | 98 | 94 | $46.50 | $4,557 |
| 92004 Ophthalmological E&M | Office | 93 | 93 | $91.88 | $8,545 |
| 99213 Office E&M - Established | Office | 91 | 83 | $56.63 | $5,153 |
| 66984 Cataract Surgery | Facility | 75 | 59 | $433.53 | $33K |
| 92250 Angiography | Office | 50 | 47 | $25.59 | $1,279 |
| 66821 Cataract Surgery | Office | 33 | 31 | $242.01 | $7,986 |
| 99212 Office E&M - Established | Office | 30 | 28 | $40.45 | $1,213 |
| 99204 Office E&M - New | Office | 25 | 25 | $98.64 | $2,466 |
| 76514 Ultrasound - Nonspecific | Office | 11 | 11 | $7.75 | $85.3 |
By year: 2022 $202K for 2,507 services; 2023 $199K for 2,428 services; 2024 $175K for 2,032 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy B Meltzer prescribed most often to Medicare patients was Restasis (Cyclosporine), with 670 prescriptions and refills. In total Jeremy B Meltzer wrote 5,678 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 670 | 943 | 157 | $552K |
| Lumigan Bimatoprost | 600 | 1,065 | 132 | $302K |
| Latanoprost Generic | 469 | 968 | 117 | $6,409 |
| Cyclosporine Generic | 451 | 500 | 91 | $148K |
| Prednisolone Acetate Generic | 436 | 525 | 243 | $17K |
| Timolol Maleate Generic | 351 | 721 | 80 | $34K |
| Ketorolac Tromethamine Generic | 304 | 343 | 159 | $6,802 |
| Erythromycin Erythromycin Base | 269 | 275 | 197 | $3,356 |
| Ofloxacin Generic | 259 | 262 | 139 | $3,000 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 249 | 482 | 58 | $3,799 |
| Cequa Cyclosporine | 229 | 312 | 56 | $177K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 142 | 215 | 35 | $20K |
| Combigan Brimonidine Tartrate/Timolol | 134 | 235 | 36 | $53K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 119 | 192 | 27 | $76K |
| Xiidra Lifitegrast | 111 | 150 | 32 | $102K |
Brand drugs: 3,627 claims; generic drugs: 2,051 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy B Meltzer $446 ($446 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $218.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $218 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $64.71 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $63.72 |
| Alcon Vision LLC ALC | 2 | $56.27 |
| Oyster Point Pharma, Inc. | 1 | $26.49 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $16.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.